Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

Dengue is prevalent in the Asia-Pacific region. Participants of two immunogenicity and safety phase II studies conducted in Singapore and Vietnam (NCT0088089 and NCT00875524, respectively) were followed for up to four years after third vaccine dose of a recombinant, live, attenuated, tetravalent den...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Tran, Ngoc Huu, Chansinghakul, Danaya, Chong, Chia Yin, Low, Chian Yong, Shek, Lynette P., Luong, Chan Quang, Fargo, Carina, Wartel, T. Anh, Sun, Sunny, Skipetrova, Anna, Bouckenooghe, Alain
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816352/
https://ncbi.nlm.nih.gov/pubmed/30724660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1578595
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires